Pharmaceuticals

Global Gene Silencing Market Size Projected to Reach $10.74 Billion During the Forecast Period

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Gene Silencing Market Over The Five-Year Period 2025–2029?

The gene silencing market size has seen swift growth in recent years. It is forecast to rise from $5.97 billion in 2024 to $6.69 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.0%. The expansion observed historically is attributable to growing research in genetic therapies, early breakthroughs in RNA interference, an increasing prevalence of genetic disorders, rising investment in biotechnology, and expanding biopharmaceutical manufacturing capabilities.

The gene silencing market is anticipated to experience substantial expansion over the upcoming years. Projections indicate it will reach $10.74 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.6%. This growth during the forecast period is attributable to several factors, including broader applications for rare diseases, innovations in delivery methods, a rising need for personalized medicine, supportive governmental efforts, and enhanced collaborations between pharmaceutical and biotechnology firms. Key trends expected over this period encompass the creation of targeted gene therapies, the proliferation of CRISPR-driven silencing techniques, a heightened emphasis on rare and orphan diseases, the advent of nanoparticle delivery systems, and its expansion into agricultural gene silencing uses.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp

What Are The Top Growth Drivers Impacting The Gene Silencing Market Outlook?

The increasing occurrence of genetic disorders is projected to boost the expansion of the gene silencing market going forward. Genetic disorders are health issues stemming from anomalies in an individual’s DNA. Their identification is growing due to advancements in diagnostic methods, greater public awareness, and wider availability of genetic testing. The rise in genetic disorders is linked to an increase in parental age, which heightens the risk of genetic mutations being passed down to children. Gene silencing presents a promising method for treating genetic disorders by specifically deactivating the expression of faulty or disease-inducing genes. For example, in August 2023, Down Syndrome UK, a charity based in the UK, reported that Down syndrome impacts an estimated 40,000 people in the UK, with approximately 1 in every 800 babies born having the condition. Consequently, the rising incidence of genetic disorders is a key factor driving the growth of the gene silencing market.

How Is The Gene Silencing Market Segmented?

The gene silencing market covered in this report is segmented –

1) By Type: Transcriptional, Post-Transcriptional, Meiotic

2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings

3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications

4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users

Subsegments:

1) By Transcriptional: DNA Methylation, Histone Modification

2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing

3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing

Which Trends Are Impacting The Gene Silencing Market?

Leading companies in the gene silencing market are concentrating on developing innovative technologies, such as small interfering RNA (siRNA), to enhance precision and efficacy in gene therapy. Small interfering RNA (siRNA) is a type of RNA molecule that plays a crucial role in the RNA interference (RNAi) pathway by binding to specific messenger RNA (mRNA) and promoting its degradation, thus preventing the production of disease-causing proteins. For example, in October 2024, Judo Bio Inc., a US-based biotechnology firm, introduced siRNA, a next-generation drug utilizing small interfering RNA (siRNA) to silence genes. Its unique attributes include proprietary delivery systems like lipid nanoparticles or conjugated ligands that ensure efficient uptake by specific cells or tissues, alongside AI-driven platforms that accelerate the identification of viable gene targets.

Which Major Firms Are Strengthening Their Position In The Gene Silencing Industry?

Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report

What Are The Regional Market Dynamics Impacting The Gene Silencing Industry?

North America was the largest region in the gene silencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gene Silencing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24224&type=smp

Browse Through More Reports Similar to the Global Gene Silencing Market 2025, By The Business Research Company

Genes Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Cell And Genes Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Cell And Gene Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795